Evidence map›Paper›PMID 27064244›Full record

ArticlePediatric research2016

Initial hyperinsulinemia and subsequent β-cell dysfunction is associated with elevated palmitate levels.

Johan Staaf, Sarojini J K A Ubhayasekera, Ernest Sargsyan, Azazul Chowdhury, Hjalti Kristinsson, Hannes Manell, Jonas Bergquist, Anders Forslund, Peter Bergsten

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Palmitate and group BFrontiers in immunology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Johan StaafDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Sarojini J K A UbhayasekeraDepartment of Chemistry-BMC, Analytical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Ernest SargsyanDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Azazul ChowdhuryDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Hjalti KristinssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Hannes ManellDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Jonas BergquistDepartment of Chemistry-BMC, Analytical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Anders ForslundDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Peter BergstenDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Uppsala University · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of obesity-related diabetes in childhood is increasing and circulating levels of nonesterified fatty acids may constitute a link. Here, the association between palmitate and insulin secretion was investigated in vivo and in vitro.

methodsObese and lean children and adolescents (n = 80) were included. Palmitate was measured at fasting; insulin and glucose during an oral glucose tolerance test (OGTT). Human islets were cultured for 0 to 7 d in presence of 0.5 mmol/l palmitate. Glucose-stimulated insulin secretion (GSIS), insulin content and apoptosis were measured.

resultsObese subjects had fasting palmitate levels between 0.10 and 0.33 mmol/l, with higher average levels compared to lean subjects. While obese children with elevated palmitate (>0.20 mmol/l) had accentuated insulin levels during OGTT, obese adolescents with high palmitate had delayed first-phase insulin response. In human islets exposed to palmitate for 2 d GSIS was twofold enhanced, but after 7 d attenuated. Intracellular insulin content decreased time-dependently in islets cultured in the presence of palmitate and cleaved caspase 3 increased.

conclusionThe rapid accentuated and delayed insulin secretory responses observed in obese children and adolescents, respectively, with high palmitate levels may reflect changes in islet secretory activity and integrity induced by extended exposure to the fatty acid.

Indexed as

AdolescentAdultAgedCells, CulturedChildChild, PreschoolCross-Sectional StudiesDiabetes ComplicationsFatty Acids, NonesterifiedFemaleGlucoseGlucose Tolerance TestHumansHyperinsulinismInsulinInsulin-Secreting CellsFatty Acids, NonesterifiedGlucoseInsulinPalmitates

Identifiers

PMID27064244
OpenAlexW2312537679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.